FRA:MED Statistics

Total Valuation

FRA:MED has a market cap or net worth of EUR 141.55 million. The enterprise value is 498.35 million.

Market Cap	141.55M
Enterprise Value	498.35M

Important Dates

The next estimated earnings date is Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	Jun 5, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	11.44M

Valuation Ratios

The trailing PE ratio is 5.70.

PE Ratio	5.70
Forward PE	n/a
PS Ratio	0.19
PB Ratio	0.64
P/TBV Ratio	0.71
P/FCF Ratio	3.33
P/OCF Ratio	1.76
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.96, with an EV/FCF ratio of 11.72.

EV / Earnings	20.06
EV / Sales	0.65
EV / EBITDA	4.96
EV / EBIT	9.92
EV / FCF	11.72

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 2.08.

Current Ratio	1.79
Quick Ratio	1.73
Debt / Equity	2.08
Debt / EBITDA	4.62
Debt / FCF	10.91
Interest Coverage	2.24

Financial Efficiency

Return on equity (ROE) is 11.90% and return on invested capital (ROIC) is 4.61%.

Return on Equity (ROE)	11.90%
Return on Assets (ROA)	3.52%
Return on Invested Capital (ROIC)	4.61%
Return on Capital Employed (ROCE)	6.79%
Revenue Per Employee	72,732
Profits Per Employee	2,372
Employee Count	10,472
Asset Turnover	0.85
Inventory Turnover	79.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.11%
50-Day Moving Average	2.92
200-Day Moving Average	2.61
Relative Strength Index (RSI)	57.34
Average Volume (20 Days)	5,618

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:MED had revenue of EUR 761.65 million and earned 24.84 million in profits. Earnings per share was 0.52.

Revenue	761.65M
Gross Profit	164.96M
Operating Income	50.26M
Pretax Income	32.12M
Net Income	24.84M
EBITDA	71.69M
EBIT	50.26M
Earnings Per Share (EPS)	0.52

Full Income Statement

Balance Sheet

The company has 107.56 million in cash and 464.13 million in debt, giving a net cash position of -356.56 million.

Cash & Cash Equivalents	107.56M
Total Debt	464.13M
Net Cash	-356.56M
Net Cash Per Share	n/a
Equity (Book Value)	222.74M
Book Value Per Share	4.68
Working Capital	131.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 80.57 million and capital expenditures -38.04 million, giving a free cash flow of 42.52 million.

Operating Cash Flow	80.57M
Capital Expenditures	-38.04M
Free Cash Flow	42.52M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.66%, with operating and profit margins of 6.60% and 3.26%.

Gross Margin	21.66%
Operating Margin	6.60%
Pretax Margin	4.22%
Profit Margin	3.26%
EBITDA Margin	9.41%
EBIT Margin	6.60%
FCF Margin	5.58%

Dividends & Yields

FRA:MED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	17.55%
FCF Yield	30.04%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:MED has an Altman Z-Score of 1.38. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.38
Piotroski F-Score	n/a